Drug profile · INN
irbesartan
APROVEL
- US status
- approved
- Patents linked
- 2
- News articles
- 0
Quick answer
irbesartan (APROVEL) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN irbesartan
Brand APROVEL
Route ORAL
Formulation TABLET
ATC code C09CA04
Originator Teva Pharma GmbH
Related patents
Search patents →Frequently asked questions
What is irbesartan?
irbesartan (APROVEL) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for irbesartan?
APROVEL is a marketed brand name for irbesartan. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of irbesartan?
irbesartan has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.